Pure Global

Liquichek Reticulocyte Control(S) - Taiwan Registration 469130ce1ef80059b47b316d169d0089

Access comprehensive regulatory information for Liquichek Reticulocyte Control(S) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 469130ce1ef80059b47b316d169d0089 and manufactured by BIO-RAD LABORATORIES. The authorized representative in Taiwan is Bio-Rad Laboratories Inc., Taiwan Branch (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
469130ce1ef80059b47b316d169d0089
Registration Details
Taiwan FDA Registration: 469130ce1ef80059b47b316d169d0089
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Liquichek Reticulocyte Control(S)
TW: ็ซ‹ๅฏๆธฌ็ถฒ็‹€็ด…่ก€็ƒๅ“็ฎกๆถฒ
Risk Class 2
MD

Registration Details

469130ce1ef80059b47b316d169d0089

Ministry of Health Medical Device Import No. 025703

DHA05602570301

Company Information

United States

Product Details

This product is used to monitor the values obtained by the automated reticular red blood cell count method.

B Hematology and pathology devices

B8625 Hematological Quality Management Mixture

Imported from abroad

Dates and Status

Dec 17, 2013

Dec 17, 2023